Fumi Honda

402 total citations
11 papers, 183 citations indexed

About

Fumi Honda is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Fumi Honda has authored 11 papers receiving a total of 183 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 6 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Fumi Honda's work include Liver Disease Diagnosis and Treatment (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Hepatitis C virus research (5 papers). Fumi Honda is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Hepatitis C virus research (5 papers). Fumi Honda collaborates with scholars based in Japan and United Kingdom. Fumi Honda's co-authors include Hiroshi Aikata, Yuko Nagaoki, Yoshiiku Kawakami, Akira Hiramatsu, Michio Imamura, Kazuaki Chayama, Kei Morio, Tomoki Kobayashi, Masataka Tsuge and Tomokazu Kawaoka and has published in prestigious journals such as PLoS ONE, Journal of Medical Virology and Journal of Gastroenterology.

In The Last Decade

Fumi Honda

11 papers receiving 177 citations

Peers

Fumi Honda
Hamad Alsuhaibani Saudi Arabia
Laurent Possenti France
Anna Maria Croce Italy
Tobias Meischl Austria
Joanna Ligocka Poland
Elsayed Mostafa Ali Egypt
Jinlong Huang China
Mutsumi Matsuyama Japan
M. Katherine Dokus United States
Beau B. Toskich United States
Hamad Alsuhaibani Saudi Arabia
Fumi Honda
Citations per year, relative to Fumi Honda Fumi Honda (= 1×) peers Hamad Alsuhaibani

Countries citing papers authored by Fumi Honda

Since Specialization
Citations

This map shows the geographic impact of Fumi Honda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumi Honda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumi Honda more than expected).

Fields of papers citing papers by Fumi Honda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumi Honda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumi Honda. The network helps show where Fumi Honda may publish in the future.

Co-authorship network of co-authors of Fumi Honda

This figure shows the co-authorship network connecting the top 25 collaborators of Fumi Honda. A scholar is included among the top collaborators of Fumi Honda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumi Honda. Fumi Honda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Honda, Fumi, Akira Hiramatsu, Hideyuki Hyogo, et al.. (2018). Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring. PLoS ONE. 13(4). e0195028–e0195028. 43 indexed citations
3.
Kawaoka, Tomokazu, Hiroshi Aikata, Yuji Teraoka, et al.. (2017). Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib. Oncology. 92(6). 335–346. 11 indexed citations
4.
Morio, Kei, Michio Imamura, Yuji Teraoka, et al.. (2017). Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury. Journal of Gastroenterology. 52(12). 1252–1257. 24 indexed citations
5.
Nagaoki, Yuko, Hiroshi Aikata, Yuji Teraoka, et al.. (2017). Risk factors for exacerbation of gastroesophageal varices and portosystemic encephalopathy during treatment with nucleos(t)ide analogs for hepatitis B virus‐related cirrhosis. Hepatology Research. 48(4). 264–274. 3 indexed citations
6.
Kawaoka, Tomokazu, Hiroshi Aikata, Yuki Inagaki, et al.. (2017). Enhanced ultrasonography detection of mucosa-associated lymphoid tissue of the liver with penetrating vessels in a tumor -case report. Kanzo. 58(5). 280–288. 4 indexed citations
7.
Kobayashi, Tomoki, Hiroshi Aikata, Fumi Honda, et al.. (2016). Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma. Journal of Computer Assisted Tomography. 40(4). 524–530. 39 indexed citations
8.
Nakamura, Yuki, Michio Imamura, Yoshiiku Kawakami, et al.. (2016). Efficacy and safety of daclatasvir plus asunaprevir therapy for chronic hepatitis C patients with renal dysfunction. Journal of Medical Virology. 89(4). 665–671. 6 indexed citations
9.
Honda, Yohji, Hiroshi Aikata, Fumi Honda, et al.. (2016). Clinical outcome and prognostic factors in hepatocellular carcinoma patients with bone metastases medicated with zoledronic acid. Hepatology Research. 47(10). 1053–1060. 12 indexed citations
10.
Nakano, Norihito, Tomokazu Kawaoka, Hiroshi Aikata, et al.. (2016). Complete response to short‐term sorafenib treatment alone for hepatocellular carcinoma with bone, lymph node, and peritoneum metastases. Hepatology Research. 46(13). 1402–1408. 3 indexed citations
11.
Nakamura, Yuki, Hiroshi Aikata, Takayuki Fukuhara, et al.. (2016). Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection. Hepatology Research. 47(8). 767–772. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hamad Alsuhaibani Breakdown of academic impact, for papers by Laurent Possenti Breakdown of academic impact, for papers by Anna Maria Croce Breakdown of academic impact, for papers by Tobias Meischl Breakdown of academic impact, for papers by Joanna Ligocka Breakdown of academic impact, for papers by Elsayed Mostafa Ali Breakdown of academic impact, for papers by Jinlong Huang Breakdown of academic impact, for papers by Mutsumi Matsuyama Breakdown of academic impact, for papers by M. Katherine Dokus Breakdown of academic impact, for papers by Beau B. Toskich
Rankless by CCL
2026